Second-generation amplification reagent set for multi-standard nucleic acid detection of microcrystalline respiratory pathogens
Taiwan·Risk Class 2·BIOFIRE DIAGNOSTICS, LLC·Registered Jul 27, 2020 – Jul 27, 2025Expired- Analysis ID
- 40a6675e6c34335836bb5b441a6c9dac
- Customs Code
- DHA05603351901
- Manufacturer
- BIOFIRE DIAGNOSTICS, LLC
- Manufacturer Country
- United States
- Authorized Representative
- BIOMERIEUX CHINA LIMITED, TAIWAN BRANCH (HONG KONG)
- Intended Use
- For details, it is Chinese approved copy of the imitation order.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3980 呼吸道病毒多標的核酸檢驗試劑
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Jul 27, 2020
- Expiry Date
- Jul 27, 2025
Access comprehensive regulatory information for Second-generation amplification reagent set for multi-standard nucleic acid detection of microcrystalline respiratory pathogens in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 40a6675e6c34335836bb5b441a6c9dac and manufactured by BIOFIRE DIAGNOSTICS, LLC. The authorized representative in Taiwan is BIOMERIEUX CHINA LIMITED, TAIWAN BRANCH (HONG KONG).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.